Drugs / YKYY031
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07631793 | May 2026 → Dec 2027 expected | cancer | Youcare Pharmaceutical Group Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YKYY031 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07631793 ↗ |
| Route | Intramuscular | “Each participant will receive a single intramuscular injection of the corresponding dose of YKYY031 for injection.” NCT07631793 ↗ |